Paragon 28, Inc. (FNA)

9,50 -1,03 (-9,78%) Alla chiusura: 04:00PM EDT

Paragon 28, Inc.

14445 Grasslands Drive
Englewood, CO 80112
United States
855 786 2828
https://paragon28.com

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 574

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Albert DaCosta	Co-Founder, Chairman, President & CEO	1,4M	N/D	1974
Ms. Kristina Wright	Independent Interim CFO & Director	70k	N/D	1977
Mr. Robert S. McCormack J.D.	General Counsel & Secretary	477,53k	N/D	1968
Mr. Matthew Jarboe	Chief Commercial Officer	899,92k	N/D	1984
Mr. Andrew James Hill	Executive Vice President of Research & Development	306,06k	N/D	1984
Mr. Jeff Sears	Vice President of Operations	N/D	N/D	N/D
Mr. Erik E Mickelson	Chief Accounting Officer & Controller	N/D	N/D	1982
Matt Brinckman	Senior Vice President of Strategy & Investor Relations	N/D	N/D	N/D
Ms. Michelle Missal	VP & Chief Compliance Officer	N/D	N/D	N/D
Mr. John Shumaker	Executive Vice President of Sales - U.S.	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

Governance aziendale

L'ISS Governance QualityScore di Paragon 28, Inc. al 1 maggio 2024 è 5. I criteri di valutazione fondamentali sono revisione: 2; Consiglio di Amministrazione: 5; diritti degli azionisti: 5; retribuzione: 7.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.